Last reviewed · How we verify
NCT04941664
Minimum Effective Local Anesthetic Volume for Ultrasound Guided Superior Trunk Block
NA trial testing 0.5% levobupivacaine in Musculoskeletal Diseases or Conditions in 25 participants. Currently enrolling.
31 July 2026
Quick facts
| Lead sponsor | Chinese University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 19 January 2023 |
| Primary completion | 31 July 2026 |
| Estimated completion | 31 August 2026 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- 0.5% levobupivacaine — full drug profile →
Conditions studied
- Musculoskeletal Diseases or Conditions — all drugs for Musculoskeletal Diseases or Conditions →
Sponsor
Chinese University of Hong Kong
Who can join
Adults 18 to 75, any sex, with Musculoskeletal Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to identify the minimum effective dosage of a commonly used local anaesthetic drug "levobupivacaine" required to produce an effective ultrasound guided (USG) superior trunk block (STB) in at least 90% of patients for shoulder arthroscopic surgeries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04941664
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 0.5% levobupivacaine
Trials testing the same drug.
- NCT05034406 — The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain · NA · completed
Other recruiting trials for Musculoskeletal Diseases or Conditions
Currently open trials in the same condition.
- NCT07360626 — Exercise and Health Education for Textile Workers: A Pre-Post Study · NA · recruiting
- NCT06773169 — IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies · NA · recruiting
- NCT06838793 — ITPB 1 vs 3 in VATS · NA · recruiting
- NCT06594120 — Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET · recruiting
- NCT06488547 — Stress and Musculoskeletal Health in Employees · NA · recruiting
Other Chinese University of Hong Kong trials
Trials by the same sponsor.
- NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
- NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
- NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
- NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
- NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04941664 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
- Last refreshed: 13 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04941664.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing